FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040429980> ?p ?o ?g. }

• W2040429980 endingPage "1071" @default.
• W2040429980 startingPage "1064" @default.
• W2040429980 abstract "Glioblastoma multiforme (GBM) is a malignant tumor of the central nervous system that directly suppresses immunological defenses in vitro and in vivo. The authors used the peripheral delivery of continuously infused granulocyte-macrophage colony-stimulating factor (GM-CSF) in the presence of irradiated tumor antigens as a tumor-specific stimulant to dendritic cells to initiate an immune response to GBM in rats.The 9L gliosarcoma tumors were established in the flanks of syngeneic Fischer 344 rats. Osmotic minipumps implanted in the animals' contralateral flanks continuously delivered recombinant GM-CSF (0, 0.1, 1, or 10 ng/day) for 28 days. Irradiated gliosarcoma cells were intermittently injected at the site of the GM-CSF infusion. Animals in the saline control group (0 ng/day GM-CSF) died on Day 59 with average tumor volumes greater than 30,000 mm3. This control group was significantly different from the GM-CSF-treated animals, which all survived with average tumor volumes that peaked on Day 23 and later regressed completely. Tumor growth as well as peak tumor volumes (5833+/-2284 mm3, 3294+/-1632 mm3, and 1979+/-1142 mm3 for 0.1, 1, and 10 ng/day GM-CSF, respectively) in the different treatment groups reflected a significant dose-response relationship with the GM-CSF concentrations. All animals treated with GM-CSF and irradiated cells were resistant to additional challenges of peripheral and intracerebral gliosarcoma, even when they were inoculated 8 months after initial immunotherapy. The colocalization of GM-CSF and inactivated tumor antigens was required to stimulate immunoprotection. To test the efficacy of a peripherally administered immunological therapy on intracerebral brain tumors the authors transplanted 10(6) gliosarcoma cells into the striatum of treated and control animals. Subcutaneous pumps that released GM-CSF (10 ng/day) and irradiated gliosarcoma cells were placed in the treated animals. The control animals all died within 31 days after intracerebral tumor implantation. In contrast, 40% of the animals receiving GM-CSF-irradiated cell vaccinations survived beyond 300 days. These long-term survivors showed no evidence of gliosarcoma at the injection site on evaluation by magnetic resonance imaging.These results suggest that the continuous localized delivery of subcutaneous GM-CSF in conjunction with inactivated tumor antigens can initiate a systemic response that leads to the regression of distant peripheral and intracerebral tumors. The success of this treatment illustrates the feasibility of tumor-specific peripheral immunological stimulation after tumor resection to prevent the recurrence of malignant brain tumors." @default.
• W2040429980 created "2016-06-24" @default.
• W2040429980 creator A5005752209 @default.
• W2040429980 creator A5016845827 @default.
• W2040429980 creator A5024409161 @default.
• W2040429980 creator A5029846774 @default.
• W2040429980 creator A5035222785 @default.
• W2040429980 creator A5035285769 @default.
• W2040429980 creator A5050118316 @default.
• W2040429980 creator A5057084504 @default.
• W2040429980 creator A5085662412 @default.
• W2040429980 creator A5046273015 @default.
• W2040429980 date "1999-06-01" @default.
• W2040429980 modified "2023-09-23" @default.
• W2040429980 title "Effects of continuous localized infusion of granulocyte—macrophage colony—stimulating factor and inoculations of irradiated glioma cells on tumor regression" @default.
• W2040429980 cites W1970570766 @default.
• W2040429980 cites W1991148746 @default.
• W2040429980 cites W2003183312 @default.
• W2040429980 cites W2008338227 @default.
• W2040429980 cites W2008921519 @default.
• W2040429980 cites W2010350911 @default.
• W2040429980 cites W2013618157 @default.
• W2040429980 cites W2014183131 @default.
• W2040429980 cites W2017519834 @default.
• W2040429980 cites W2017605183 @default.
• W2040429980 cites W2024018223 @default.
• W2040429980 cites W2026159355 @default.
• W2040429980 cites W2027159794 @default.
• W2040429980 cites W2034551415 @default.
• W2040429980 cites W2040248930 @default.
• W2040429980 cites W2040327439 @default.
• W2040429980 cites W2049214772 @default.
• W2040429980 cites W2051895246 @default.
• W2040429980 cites W2058728489 @default.
• W2040429980 cites W2084906660 @default.
• W2040429980 cites W2135272173 @default.
• W2040429980 cites W2135896827 @default.
• W2040429980 cites W2165894897 @default.
• W2040429980 cites W2166484715 @default.
• W2040429980 cites W2166676682 @default.
• W2040429980 cites W2177327503 @default.
• W2040429980 cites W2332278629 @default.
• W2040429980 cites W2423112668 @default.
• W2040429980 cites W4244591305 @default.
• W2040429980 cites W2056261712 @default.
• W2040429980 doi "https://doi.org/10.3171/jns.1999.90.6.1064" @default.
• W2040429980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10350253" @default.
• W2040429980 hasPublicationYear "1999" @default.
• W2040429980 type Work @default.
• W2040429980 sameAs 2040429980 @default.
• W2040429980 citedByCount "39" @default.
• W2040429980 countsByYear W20404299802012 @default.
• W2040429980 countsByYear W20404299802014 @default.
• W2040429980 countsByYear W20404299802017 @default.
• W2040429980 crossrefType "journal-article" @default.
• W2040429980 hasAuthorship W2040429980A5005752209 @default.
• W2040429980 hasAuthorship W2040429980A5016845827 @default.
• W2040429980 hasAuthorship W2040429980A5024409161 @default.
• W2040429980 hasAuthorship W2040429980A5029846774 @default.
• W2040429980 hasAuthorship W2040429980A5035222785 @default.
• W2040429980 hasAuthorship W2040429980A5035285769 @default.
• W2040429980 hasAuthorship W2040429980A5046273015 @default.
• W2040429980 hasAuthorship W2040429980A5050118316 @default.
• W2040429980 hasAuthorship W2040429980A5057084504 @default.
• W2040429980 hasAuthorship W2040429980A5085662412 @default.
• W2040429980 hasConcept C142724271 @default.
• W2040429980 hasConcept C147483822 @default.
• W2040429980 hasConcept C150903083 @default.
• W2040429980 hasConcept C202751555 @default.
• W2040429980 hasConcept C203014093 @default.
• W2040429980 hasConcept C207001950 @default.
• W2040429980 hasConcept C2777295375 @default.
• W2040429980 hasConcept C2777478134 @default.
• W2040429980 hasConcept C2777701055 @default.
• W2040429980 hasConcept C2777983669 @default.
• W2040429980 hasConcept C2778227246 @default.
• W2040429980 hasConcept C2778690821 @default.
• W2040429980 hasConcept C2779130545 @default.
• W2040429980 hasConcept C502942594 @default.
• W2040429980 hasConcept C55493867 @default.
• W2040429980 hasConcept C71924100 @default.
• W2040429980 hasConcept C86803240 @default.
• W2040429980 hasConcept C8891405 @default.
• W2040429980 hasConceptScore W2040429980C142724271 @default.
• W2040429980 hasConceptScore W2040429980C147483822 @default.
• W2040429980 hasConceptScore W2040429980C150903083 @default.
• W2040429980 hasConceptScore W2040429980C202751555 @default.
• W2040429980 hasConceptScore W2040429980C203014093 @default.
• W2040429980 hasConceptScore W2040429980C207001950 @default.
• W2040429980 hasConceptScore W2040429980C2777295375 @default.
• W2040429980 hasConceptScore W2040429980C2777478134 @default.
• W2040429980 hasConceptScore W2040429980C2777701055 @default.
• W2040429980 hasConceptScore W2040429980C2777983669 @default.
• W2040429980 hasConceptScore W2040429980C2778227246 @default.
• W2040429980 hasConceptScore W2040429980C2778690821 @default.
• W2040429980 hasConceptScore W2040429980C2779130545 @default.
• W2040429980 hasConceptScore W2040429980C502942594 @default.
• W2040429980 hasConceptScore W2040429980C55493867 @default.

• next